Literature DB >> 12455028

Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer.

Shinichi Toyooka1, Riichiroh Maruyama, Kiyomi O Toyooka, Dale McLerran, Ziding Feng, Yasuro Fukuyama, Arvind K Virmani, Sabine Zochbauer-Muller, Kazunori Tsukuda, Kenji Sugio, Nobuyoshi Shimizu, Kenji Shimizu, Huei Lee, Chih-Yi Chen, Kwun M Fong, Michael Gilcrease, Jack A Roth, John D Minna, Adi F Gazdar.   

Abstract

Aberrant methylation of several known or putative tumor suppressor genes occurs frequently during the pathogenesis of lung cancers. There are major smoke exposure, histology, geography and gender-related changes in non-small cell lung cancer (NSCLC). We investigated smoking-related, histologic, geographic and gender differences in the methylation profiles of resected NSCLCs. We examined 514 cases of NSCLC and 84 corresponding nonmalignant lung tissues from 4 countries (USA, Australia, Japan and Taiwan) for the methylation status of 7 genes known to be frequently methylated in lung cancers [p16, RASSF1A (RAS association domain family 1), APC, RARbeta, CDH13, MGMT and GSTP1]. Multivariate analyses were used for data analysis. Adenocarcinoma was the major histologic type in women and never smokers; analyses that involved smoke exposure and gender were limited to this histology. Our major findings are a) methylation status of any single gene was largely independent of methylation status of other genes; b) the rates of methylation of p16 and APC and the mean Methylation Index (MI), a reflection of the overall methylation status, were significantly higher in ever smokers than in never smokers; c) the mean MI of tumors arising in former smokers was significantly lower than the mean of current smokers; d) the methylation rates of APC, CDH13 and RARbeta were significantly higher in adenocarcinomas than in squamous cell carcinomas; e) methylation rates of MGMT and GSTP1 were significantly higher in the USA and Australian cases than in those from Japan and Taiwan; and (f) no significant gender-related differences in methylation patterns were noted. Our findings demonstrate important smoke exposure, histologic type and geography-related differences in the methylation profiles of NSCLC tumors. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12455028     DOI: 10.1002/ijc.10787

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  76 in total

Review 1.  Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.

Authors:  Satish Kalari; Gerd P Pfeifer
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

2.  Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma.

Authors:  Milica Kontic; Jelena Stojsic; Dragana Jovanovic; Vera Bunjevacki; Simona Ognjanovic; Jacquelyn Kuriger; Susan Puumala; Heather H Nelson
Journal:  Clin Lung Cancer       Date:  2011-12-13       Impact factor: 4.785

3.  Basal-like breast cancer displays distinct patterns of promoter methylation.

Authors:  Ji Shin Lee; Mary Jo Fackler; Jae Hyuk Lee; Chan Choi; Min Ho Park; Jung Han Yoon; Zhe Zhang; Saraswati Sukumar
Journal:  Cancer Biol Ther       Date:  2010-06-18       Impact factor: 4.742

4.  Mortality in the randomized, controlled lung intergroup trial of isotretinoin.

Authors:  J Jack Lee; Lei Feng; Daniel S Reshef; Anita L Sabichi; Brendell Williams; Waree Rinsurongkawong; Ignacio I Wistuba; Reuben Lotan; Scott M Lippman
Journal:  Cancer Prev Res (Phila)       Date:  2010-05-25

Review 5.  Epigenetics of lung cancer.

Authors:  Scott M Langevin; Robert A Kratzke; Karl T Kelsey
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

6.  Native American ancestry affects the risk for gene methylation in the lungs of Hispanic smokers from New Mexico.

Authors:  Shuguang Leng; Yushi Liu; Cynthia L Thomas; W James Gauderman; Maria A Picchi; Shannon E Bruse; Xiequn Zhang; Kristina G Flores; David Van Den Berg; Christine A Stidley; Frank D Gilliland; Steven A Belinsky
Journal:  Am J Respir Crit Care Med       Date:  2013-11-01       Impact factor: 21.405

Review 7.  Second-hand smoke and human lung cancer.

Authors:  Ahmad Besaratinia; Gerd P Pfeifer
Journal:  Lancet Oncol       Date:  2008-07       Impact factor: 41.316

8.  Quantitative detection of TUSC3 promoter methylation -a potential biomarker for prognosis in lung cancer.

Authors:  Uta Duppel; Matthias Woenckhaus; Christian Schulz; Johannes Merk; Wolfgang Dietmaier
Journal:  Oncol Lett       Date:  2016-08-01       Impact factor: 2.967

9.  DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients.

Authors:  Qinghua Feng; Stephen E Hawes; Joshua E Stern; Linda Wiens; Hiep Lu; Zhao Ming Dong; C Diana Jordan; Nancy B Kiviat; Hubert Vesselle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

10.  Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients.

Authors:  Yang Liu; Qing Lan; Jill M Siegfried; James D Luketich; Phouthone Keohavong
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.